Page 269 - Wasserstoff Medizin
P. 269

performance enhancement (ergogenic effects). More energy out of every breath you take,
                  which is like the claims made when using singlet oxygen therapy.

























                  Dr. Dominic D'Agostino, a researcher and assistant professor with the University of South
                  Florida Morsani College of Medicine, said “cancer is starved” by eating a diet that is
                  restricted in carbohydrates but high in certain fats. The patient then receives hyperbaric
                  chamber treatments, in  which  oxygen has  a further toxic effect on the cancer cells,
                  explaining a possible one-two punch to knock out cancer.


                  D'Agostino began research nine years ago involving metabolic therapy and hyperbaric
                  oxygen to help Navy SEAL divers avoid seizures from oxygen toxicity. A 10-year-old
                  boy with  a cancerous brain tumor who had already received a battery  of traditional
                  conventional radiation therapy has gotten positive results from this. The youth responded
                  “remarkably” to the combination of diet and hyperbaric treatment.


                  Low-level electromagnetic fields are known  and used to  halt cancer cell growth.
                  Pulsed Magnetic Field Therapy (PEMF) is FDA approved to promote the healing of non-
                  healing bone unions and has been used in Europe for over 20 years in 400,000 sessions
                  with individuals with cancer,  migraines, sports related injuries, wound healing and other
                                              lxx
                  pain syndromes. PEMF-based anticancer strategies represent a new therapeutic approach
                  to treat breast cancer without affecting normal tissues in a manner that is non-invasive
                  and can be potentially combined with existing anti-cancer treatments.
                                                                                     lxxi
                         Costa et al (2011) reported surprising clinical benefits from using the specific
                         EMF signals to treat advanced hepatocellular carcinoma, stabilizing the disease
                         and even producing partial responses up to 58 months in a subset of the patients.
                         Now Zimmerman et al have examined the growth rate of human tumor cell lines
                         from liver and breast cancers along with normal cells from those tissues exposed
                         to AM-EMF. Reduced growth rate was observed for tumor cells exposed to tissue-
                         specific AM-EMF, but no change in growth rate in normal cells derived from the
                         same tissue type, or in tumor or normal cells from the other tissue type.
                                                                                              lxxii



                                                           269
   264   265   266   267   268   269   270   271   272   273   274